Sona Stock Up 123% on Test Results

Shares of Halifax-based Sona Nanotech more than doubled Friday after the nanoparticle technology company said clinical trials showed its COVID-19 rapid testing kit has a 96 percent sensitivity to the virus.

The company’s shares on the Canadian Stock Exchange surged $3.84 or 123 percent, closing at $6.97 on Friday. The shares opened 2020 at 11 cents, and have produced a 6200 percent return so far

Continue Reading

Let’s Begin to Build a Respectful Society

I am very proud to be at the University of New Brunswick and call Atlantic Canada home. The whole conversation around racism is a very hard conversation to have with my kids and students because you simply have to look around and it is obvious that this a very serious issue. 

I was a minority growing up in Zambia and then a minority in the U.K. for my education and finally a minority in Canada,

Continue Reading

3D Planeta Revamps Strategy, Raising Funds

In the wake of a comprehensive retooling of its business development strategy, Fredericton geo-mapping startup 3D Planeta is in the process of raising a seven-figure funding round.

CEO Norm Couturier said in an interview that the reworked sales and marketing strategy was in response to COVID-19 rendering the company’s previous, travel-heavy approach unworkable.

After several months spent

Continue Reading

Businesses Must Be Welcoming

Imagine a house. All your life, you're told you don't belong in that house, and the doors are locked. In order to enter the house, you have to look, act, and talk like the people who live there.

Imagine one day they open up the doors and windows and ask each other, “Why is no one coming in?” Imagine you walk in, and the people inside don’t think you deserve to be there. Imagine you speak, but no

Continue Reading

Technow Named BioAlliance Chair

​Oliver Technow, CEO of Charlottetown-based BioVectra, was named the new chair of the PEI BioAlliance’s board of directors on Monday.

Technow has been a member of the board of the life sciences industry association since 2017. BioVectra, which manufactures ingredients for prescription drugs, was sold last year to U.S. Private Equity firm H.I.G. Capital for about C$330 million.

The BioAlliance

Continue Reading
Read More Blog Posts